|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
PHAGOCYTES
From the University Children's Hospital, Department of
Hematology and Oncology, Tübingen, Germany; University of
Freiburg, Pharmaceutical Institute, Department of Pharmaceutical
Technology, Freiburg, Germany; and University of Zurich, Laboratory for
Electron Microscopy, Zurich, Switzerland.
Chronic granulomatous disease (CGD) is an inherited primary
immunodeficiency characterized by phagocytes devoid of a functioning nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The failure of CGD phagocytes to produce reactive oxygen species (ROS) results in a marked increase in the susceptibility of affected patients
to life-threatening bacterial and fungal infections. This study
investigated whether loading of CGD phagocytes with glucose oxidase
(GO)-containing liposomes (GOLs) could restore cellular production of
bactericidal ROS (eg, H2O2 and HOCl) in vitro.
Results indicate that GO encapsulated in liposomes enabled NADPH
oxidase-deficient phagocytes to use H2O2 for
the production of highly bactericidal HOCl. The intracellular
colocalization of bacteria and liposomes (or liposome-derived ferritin)
was demonstrated by confocal laser microscopy and electron microscopy.
After uptake of GOLs (approximately 0.2 U/mL at 1 mM total lipid
concentration, size approximately 180 nm), CGD granulocytes produced
HOCl levels comparable to those of normal phagocytes. Remarkably, after
treatment with GOLs, CGD phagocytes killed Staphylococcus
aureus as efficiently as normal granulocytes. Moreover, treated
cells retained sufficient motility toward chemotactic stimuli as
measured by chemotaxis assay. Side effects were evaluated by measuring
the H2O2 concentrations and the production of
methemoglobin in whole blood. These studies revealed that
H2O2 produced by GOLs was degraded immediately
by the antioxidative capacity of whole blood. Elevated methemoglobin levels were observed only after application of extremely high amounts
of GOLs (2 U/mL). In summary, the application of negatively charged
GOLs might provide a novel effective approach in the treatment of
patients with CGD at high risk for life-threatening infections.
(Blood. 2001;98:3097-3105) Chronic granulomatous disease (CGD) is a primary
immunodeficiency with an incidence of 1:1 000 000 to
1:250 000.1 It is an inherited disorder (X
chromosomal or autosomal recessive) of the phagocyte
system.2 Phagocytes (granulocytes and monocytes) of
patients with CGD lack a functional nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and are not able to produce reactive oxygen
species (ROS), necessary for microbial killing.3 The disease is therefore dominated by high susceptibility to a variety of
bacteria and fungi, especially those with catalase
activity.4 Therapy and prevention of infections include
the life-long administration of antibiotics and antimycotics, and in
severe cases, the transfusion of allogeneic granulocytes to provide the
patient with functioning phagocytes.5
In recent years the idea of encapsulating drugs such as
antibiotics or cytostatics into liposomal carriers has become more feasible.6 Phagocytes tend to take up conventional
liposomes very easily.7 This uptake is often a
disadvantage in the use of liposomes for many medical applications and
clinical trials because of rapid elimination of the encapsulated drug.
We developed glucose oxidase (GO)-containing liposomes (GOLs) that
were successfully phagocytosed either by normal or CGD phagocytotic
cells. The positive effects of H2O2 derived
from GO or GO bound to latex beads in CGD cells were reported by
several investigators.8,9 The idea of restoring the
H2O2 production of CGD cells with the use of
GOLs was first considered by Ismail and coworkers10 20 years ago. It was not further followed up because of a poor knowledge of liposome preparation methods at that time. However, present liposome
technology and research allow a wide range of possible applications. In the case of CGD, therapeutic application of GOLs for the restoration of ROS production could be useful because phagocytes of patients with CGD have a normal myeloperoxidase (MPO)
activity.11 The GO-derived H2O2
can be converted within CGD phagocytes into the strong oxidant
HOCl during the MPO reaction:
Subjects and cell preparation
Preparation of liposomes Liposomes made up of different lipid compositions were prepared by extrusion (see below). Egg phosphatidylcholine (EPC), egg phosphatidylglycerol (EPG), and soy phosphatidylserine (SPS) were kindly provided by Lipoid (Ludwigshafen, Germany). Cholesterol (Chol) was obtained from Sigma. The lipid mixture (EPC:SPS:Chol or EPC:EPG:Chol, each 4:3:3 mole ratio, or EPC:Chol, 7:3 mole ratio) was dissolved in dichloromethane or methanol or both. For fluorescence-activated cell sorter (FACS) analysis 1 mol% rhodamine-B-phosphatidylethanolamine (PE; Molecular Probes, Leiden, The Netherlands) was added as fluorescent lipid label. The organic solvent was removed completely under reduced pressure and the lipid film was dissolved in an isotonic phosphate buffer. For encapsulation of GO (Aspergillus niger, Boehringer Mannheim, Mannheim, Germany), the liposomes consisted either of EPC:SPS:Chol or EPC:EPG:Chol (each 4:3:3 mole ratio). The lipid film was dispersed in an isotonic phosphate buffer containing 6 mg/mL GO to yield a total lipid concentration of 20 mM. The dispersion was freeze-thawed 5 times before extrusion. For all liposome preparations the dispersion was extruded 21 times through a polycarbonate membrane with 0.2 µm pores (Nuclepore, Pleasanton,). It ensured sufficient sizing of liposomes and achieving an average number of lipid lamellae of 1 to 2. Unencapsulated GO was removed by gel chromatography on Sepharose 4B-CL. Liposomes were concentrated by ultracentrifugation with 150 000g for 180 minutes (LE-80 Ultracentrifuge, Rotor 50.4 Ti, Beckman, Munich, Germany). The resulting lipid concentration was 20 mM, the GO-trapping efficiency was 5%, and approximately 0.2 U/mL related to 1 mM total lipid concentration, as measured by GO liposomal H2O2 production.13 The particle size was measured by photon correlation spectroscopy using a Zetamaster S (Malvern Instruments, Malvern, United Kingdom).Preparation of ferritin liposomes The preparation of ferritin-containing liposomes, used for electron microscopic studies, was carried out similarly to GOLs. A solution of 50 mg/mL ferritin (type I, from horse spleen, Sigma) instead of GO was added to the lipid film. Extrusion was performed without the prior freezing-thawing step to avoid damage of the freeze-sensitive ferritin. Free ferritin was removed from liposomes by gel chromatography.Uptake analysis The uptake of fluorescence-labeled liposomes by leukocytes in whole blood was evaluated by FACS analysis (Becton Dickinson, Heidelberg, Germany) with a total count of 10 000 cells. Data were analyzed using the Lysis II program from Becton Dickinson. Heparinized whole blood (100 µL) was incubated with rhodamine-labeled liposomes (1 mM total lipid concentration) at 37°C for 0, 20, 40, and 60 minutes. After incubation, red blood cells were lysed using an ammonium chloride buffer; the remaining leukocytes were washed 3 times in PBS and stored on ice in the dark until measurement.Intracellular location of GOL and S aureus Intracellular location was evaluated by confocal laser microscopy (TCS4D, Leica Microscopy, Wetzlar, Germany) and by transmission electron microscopy (Philips EM 208S, Eindhoven, The Netherlands). For confocal analyses 500 000 granulocytes were incubated in a total volume of 500 µL PBS with 5 × 106 S aureus particles (cell-to-bacteria ratio 1:10) labeled with BODIPY (Molecular Probes, Eugene, OR) at 37°C for 15 minutes. Cells were washed twice in ice-cold PBS and resuspended in PBS/glucose (0.1% w/v). EPC:EPG:Chol liposomes (1 mM lipid), rhodamine-labeled, were added and further incubated for 20 minutes. Cells were washed and fixed with 2% paraformaldehyde.For electron microscopy, 15 million granulocytes were incubated in a total volume of 1000 µL PBS with 15 × 107 S aureus particles (cell-to-bacteria ratio 1:10) and ferritin liposomes (3 mM lipid) at 37°C for 60 minutes. In parallel, granulocytes were incubated as described for confocal analyses or, as negative control, only with plain liposomes. Cells were washed and fixed with glutaraldehyde (2.5% in PBS, v/v) at 4°C for 30 minutes. Cells were further fixed with OsO4 (2% in PBS, w/v). Block staining was performed overnight in uranyl acetate (2% in aqua destillata, w/v). Samples were dehydrated in a graded series of ethanol concentrations and polymerized in Epon 812 (Fluka, Buchs, Switzerland). Ultrathin sections were cut and mounted on copper grids. Flow cytometric analysis of GO activity in granulocytes Granulocytes (500 000) were incubated with GOLs (1 mM lipid) in a total volume of 500 µL in PBS at 37°C for 15 minutes. Cells were washed 3 times in ice-cold buffer and resuspended in 500 µL PBS/glucose (0.1% w/v) and incubated at 37°C for different time periods. At the end of the incubation time cells were placed on ice, and dihydrorhodamine 123 (DHR; 0.01 mg/mL; Molecular Probes) was added and the cells were further incubated for 15 minutes. Tubes were placed on ice, washed once with PBS, and measured immediately by FACS analysis (Becton Dickinson) using live-gate for at least 10 000 cells.Production of HOCl Production of HOCl was measured by chlorination of taurine followed by the oxidation of 5-thio-2-nitrobenzoic acid (TNB) to 5,5'-dithio-bis(2-nitrobenzoic) acid (DTNB, Sigma). Briefly, 5 × 106 granulocytes/mL were incubated in HBSS plus taurine (15 mM) with GOLs (1 mM total lipid concentration) at 37°C for 30 minutes. The reaction was stopped by adding catalase (290 U/mL) and samples were centrifuged at 12 000g for 10 minutes. Supernatant was mixed with TNB (2 mM) and immediately measured at 412 nm. The amount of HOCl was calculated using the molar linear absorption coefficient of = 1410 m2/mol.
Killing assay The killing assay was performed according to Metcalf and colleagues14 with slight modifications. In brief, S aureus (American Type Culture Collection 25923) was opsonized with 10% pooled human serum and then added to normal and CGD granulocytes in HBSS/0.1% (w/v) gelatin at a bacterium-to-granulocyte ratio of 1:1 (5 × 105 bacteria and granulocytes, respectively). Granulocytes were either pretreated with GOLs (1 mM lipid, approximately 0.2 U/mL GO) at 37°C for 15 minutes in PBS without glucose, then washed 3 times in PBS and mixed with bacteria, or incubated directly with liposomes and bacteria. Tubes were rotated at 37°C and the killing was stopped after 0, 1, and 2 hours by adding ice-cold distilled water. Tubes were mixed and diluted 1:50 and 1:250 with HBSS. Fifty microliters of the dilution was plated on trypticase-soy agar (Bio-Mérieux, Berlin, Germany). Total viable bacteria were counted as colonies after 12 hours of incubation at 37°C.Degranulation of granulocytes by liposomes About 3 million granulocytes were incubated with plain liposomes (1 mM lipid) or as positive control, with cytochalasin B and N-formyl-Meth-Leu-Phe (NfMLP; 0.5 µg/mL and 10 6 M,
respectively) in dimethylsulfoxide (DMSO) at 37°C for 0 and 30 minutes. Degranulation was followed by measuring the samples by flow cytometry using the Bayer ADVIA120.
Chemotaxis assay Chemotaxis assay was performed by the gelatin-agarose migration assay according to Cline15 with slight modifications. One million granulocytes in HBSS were incubated in slots of prepared gelatin-agarose slides and migrated against 1 nmol/mL NfMLP (Sigma) and 1 nmol/mL leukotriene B4 (LTB4, Sigma) at 37°C in a humidified atmosphere for 2 hours. Granulocytes were incubated with GOLs (1 mM total lipid) in PBS without glucose (to prevent premature H2O2 production) at 37°C for 15 minutes and then washed 3 times in PBS. Migration was stopped by fixation of the slides in 2.5% (v/v) glutaraldehyde (Merck, Darmstadt, Germany) for 30 minutes. Agarose was washed away and slides were stained by Pappenheim. Spontaneous migration was subtracted from migration against chemotactic agent by microscopic analysis.Methemoglobin production and glucose consumption Methemoglobin and glucose were determined using the blood gas analyser ABL 700 (Radiometer, Willich, Germany). Liposomal GO was incubated in different concentrations (liposomal GO: 2, 0.2, and 0.002 U/mL; respectively 10, 1, and 0.01 mM total lipid concentration) together with 0.1 mL heparinized whole blood at 37°C for 0 to 120 minutes. Samples were measured immediately after stopping the reaction on ice.H2O2 concentration The concentration of H2O2 in whole blood or PBS/0.1% (w/v) glucose was measured according to Thurman and coworkers.13 Liposomal GO was incubated in different concentrations (liposomal GO: 2, 0.2, and 0.002 U/mL; 10, 1, and 0.01 mM total lipid concentration) at 37°C for 0 to 120 minutes.
Uptake of different types of liposomes Flow cytometric analysis of the uptake of 2 fluorescence-labeled types of negatively charged liposome formulations (EPC:SPS:Chol and EPC:EPG:Chol; size: 160 ± 10 nm and 180 ± 10 nm, respectively) and one uncharged liposome type (EPC:Chol, size: 200 ± 10 nm) revealed that negatively charged liposomes are phagocytosed preferentially by granulocytes and monocytes (Figure 1A). In contrast, less than 10% of the lymphocyte population showed liposome association. The uptake of liposomes by granulocytes was time-dependent (Figure 1B). Based on these analyses all further experiments were performed with negatively charged liposomes (EPC:SPS:Chol and EPC:EPG:Chol). Confocal microscopic analysis of subsequent incubation of granulocytes with S aureus (green) and liposomes (red, EPC:EPG:Chol) demonstrated that both are localized mainly inside the phagocyte. Color overlay (yellow) indicates the colocalization of bacteria and liposomes (Figure 2A). With the electron microscopic analyses we can show that some of the bacteria are located inside the same vacuole with ferritin, derived from the uptake of ferritin-containing liposomes (Figure 2C,D). The negative control with plain liposomes failed to show the electron-dense structure (not shown). Both confocal laser microscopy and electron microscopy gave no evidence for extracellular membrane attachment of liposomes.
MPO activity The basic requirement for the successful application of GOLs in CGD cells is the presence of an active MPO inside the NADPH oxidase-deficient (CGD) phagocytes. The MPXI of normal and CGD neutrophils from the patients of this study ranged between 10 and
+10, indicating normal MPO activity (Figure
3A,C). For comparison, an
H3-leukogram of a person with MPO deficiency (MPXI = 56) is shown where the neutrophil cloud shifted to the left due to lack of MPO
(Figure 3B).
Intracellular GO activity after uptake of GOLs by CGD granulocytes The detection of H2O2-positive granulocytes with the DHR assay revealed that the amount of fluorescence-positive cells was stable for 180 minutes. The mean fluorescence of intracellular DHR oxidation began to decrease after 15 to 30 minutes (Figure 4A). The extracellular addition of catalase (50 U/mL) diminished the H2O2 concentration outside the granulocytes. There was no additional decrease in DHR-detectable H2O2 production with higher concentrations of catalase (Figure 4B). The amount and the mean fluorescence of DHR+ cells by catalase addition decreased over 180 minutes. After this time no further loss was observed. Furthermore, the DHR assay revealed that there are still H2O2-producing CGD granulocytes after 8 hours (75% fluorescence-positive cells at 8 hours after loading the cells with GOL (EPC:EPG:Chol; mean, n = 2). Results are shown only for EPC:EPG:Chol liposomes, but those for EPC:SPS:Chol were comparable.
HOCl production Native CGD cells, which are unable to produce HOCl due to their NADPH oxidase defect, produced comparable amounts of HOCl to those of normal granulocytes when treated with GOLs (Figure 5). Cells were preincubated with GOLs, the unbound liposomes were washed out, and the incubation was continued in glucose-containing medium for 30 minutes. When the incubation was carried out without removal of GOLs, the amount of produced HOCl was, of course, higher in both cell types (for SPS: 180 ± 36 and 167.5 ± 35.5 nmoles/30 min; for EPG: 184.5 ± 26.5 and 138.5 ± 55.5 nmoles/30 min, normal and CGD, respectively). Therefore at least 15% of the HOCl production within CGD cells resulted from incorporation of GOLs (Figure 5). No HOCl could be detected in the presence of 1 mM L-methionine, a scavenger of HOCl. There was no significant difference for both liposome formulations.
Killing of S aureus The bactericidal activity of GOL-treated granulocytes was investigated by killing of S aureus. Untreated CGD granulocytes (without liposome addition) showed no reduction of bacterial growth after 1 hour (98% ± 22%; n = 3) compared to normal controls, and only a slight decrease after 2 hours (89% ± 24%; n = 3; Figure 6). Normal granulocytes reduced the bacterial growth to 75% ± 22% after 1 hour and to 69% ± 14% after 2 hours of incubation. Interestingly, CGD cells preincubated with GOLs (nonincorporated liposomes were removed with the supernatant after 15 minutes by washing the cells with PBS) showed the most effective and significant killing of S aureus after 2 hours (65% ± 13% for EPC:SPS:Chol and 66% ± 7% for EPC:EPG:Chol, respectively) compared to untreated CGD control. Incubation of bacteria alone with GOLs showed no reduction of their growth.
Effect of liposomes on degranulation Granulocytes that are confronted with phagocytosable liposomes may react with degranulation. For detection of degranulation, release of MPO from azurophilic granules was measured16 using the Bayer ADVIA120. Incubation of isolated granulocytes with cytochalasin B/NfMLP for 30 minutes resulted in a clear shift of the granulocyte cloud to the left, indicating an intense release of MPO. In contrast, no shift was observed after incubation with plain liposomes and GOLs (Figure 7).
Chemotaxis after GOL treatment The effect of GOL treatment of normal and CGD cells was tested by their migration toward chemotactic stimuli such as NfMLP (Figure 8A) or LTB4 (Figure 8B). The preincubation of granulocytes with GOLs resulted in a significant decrease of the migration distance. Nevertheless, granulocytes retained motility toward the chemotactic stimuli after ingestion of GOLs. Statistical analysis revealed differences after preincubation of CGD cells with liposomes compared to normal cells (as indicated with the asterisk in Figure 8).
H2O2 concentration and methemoglobin formation in whole blood samples after incubation with GOLs Possible side effects of GOL treatment in whole blood samples (glucose concentration, 3.1-6.4 mM) were investigated by measuring the net concentration of H2O2 (production minus degradation) and generation of methemoglobin as a response parameter to this potential oxidative stress. A wide range of GO concentrations (0.002, 0.2, and 2 U/mL or 0.01, 1, and 10 mM lipid) encapsulated in EPC:SPS:Chol and EPC:EPG:Chol liposomes showed generally the same results concerning H2O2 occurrence. The results shown in Figure 9 are exemplary only for EPS:SPS:Chol liposomes. To differentiate between H2O2 production and degradation, parallel incubations were carried out in PBS containing 5.6 mM glucose (physiologic concentration). H2O2 measurements (Figure 9) showed a time- and a dose-dependent production of H2O2 in PBS/glucose, where no H2O2 degradation is possible. In contrast, H2O2 could not be detected in whole blood samples, even at the highest GO concentration (2 U/mL).
As a consequence, methemoglobin generation in whole blood (Figure
10) was absent using 0.002 and 0.2 U/mL
GO. Only slightly elevated values were observed after incubation with
the extremely high concentration of GO (2 U/mL).
Granulocytes provide a first line of defense against invading pathogens such as bacteria and fungi. Once activated (ie, through phagocytosis), granulocytes produce ROS, which play a central role in the destruction of ingested microorganisms.17 In the phagocytes of patients with CGD, the production of ROS is disturbed due to a defect in NADPH oxidase,18 whereas MPO is active in azurophilic granules.11 This was demonstrated again for the CGD granulocytes and monocytes used in this study. Despite long-term administration of antibiotics and antimycotics in patients with CGD, the risk of life-threatening infections is high.1 Above all, the most difficult complications are caused by fungi (eg, Aspergillus species), a variety of gram-negative enteric bacilli, and catalase-positive bacteria (eg, S aureus)19,20 able to destroy endogenous H2O2. This hampers CGD granulocytes in HOCl production using their own MPO. In the late 1970s, the idea of replacing defective H2O2 production after phagocytosis of GO encapsulated in liposomes was first described.10 Encouraging results could not be followed up because of insufficient liposome technology at that time. In this study we asked whether GOLs could initiate HOCl production and consequently reconstitute the killing ability of CGD cells against S aureus after their uptake by leukocytes. For this purpose, we tested different liposome formulations for their specific uptake by phagocytic leukocytes. We demonstrate here specific uptake of negatively charged liposomes (EPC:SPS:Chol and EPC:EPG:Chol) by phagocytes (granulocytes and monocytes). Only a low percentage of fluorescence-positive lymphocytes after incubation with liposomes was observed. The charge of the liposome membrane proved to be important for phagocytosis. Uncharged liposomes (EPC:Chol) showed a significantly lower percentage of fluorescence-positive cells compared to the other liposome formulations, especially for granulocytes. The importance of surface charge, specific headgroups, and liposome size for monocytes and macrophages has been demonstrated by many investigators.21-23 Based on these results, monocytes and granulocytes were proven to be ideal target cells for EPC:SPS:Chol/EPC:EPG:Chol liposomes. Related to these results are reports showing rapid uptake of conventional negatively charged liposomes by macrophages of the liver and the reticuloendothelial system (RES).7,24 For many drug-targeting applications this feature of conventional liposomes might be disadvantageous. However, in the case of CGD, formulation of conventional negatively charged liposomes now provides an excellent source for GO delivery to the phagocytes. The intracellular location of GOLs after incubation with granulocytes and the subsequent intracellular production of H2O2 and HOCl was indicated by several independent experiments. The flow cytometry data showed a preferential uptake of GOLs by phagocytes. If the binding to the outside of the cell membrane were nonspecific, a similar pattern would be expected for phagocytes as well as for lymphocytes. Additional details about the localization of GOL and S aureus inside the granulocytes were obtained by confocal laser microscopy. These studies strongly suggest that GOLs are taken up via phagocytosis. After preincubation of granulocytes with S aureus and subsequent addition of liposomes, we observed an intracellular localization of bacteria and liposomes, reflecting their close intracellular contact. Some liposomes and bacteria seem to be colocalized inside the phagolysosomes (yellow spots). Previously, Ho and Huang showed the phagocytosis of liposomes followed by a fusion of the phagosome with lysosomes inside the cells by electron microscopy.25 In our electron microscopic analyses using ferritin-containing liposomes,26 we found vacuoles where bacteria and ferritin were localized together, suggesting a fusion of liposomes with the phagosome. Uptake and intracellular activity of GOLs was further evidenced by DHR 123 oxidation through GO-derived H2O2.27,28 CGD granulocytes showed no detectable DHR oxidation after stimulation with phorbol-myristate-acetate. However, the DHR oxidation was already detectable after only 5 minutes of incubation with GOLs. Addition of catalase decreased the intracellular concentration of H2O2 to some extent. This may be due to diffusion of intracellularly produced H2O2 into the extracellular space, thereby scavenged by catalase before penetrating other cells.9 Experiments in which normal or MPO-deficient granulocytes were mixed with CGD granulocytes showed that H2O2 diffused through the membrane and could be used by CGD cells for the HOCl production and consequently for microbicidal killing.29,30 As shown in Figure 4, intracellular DHR oxidation decreased after 15 to 30 minutes under our experimental conditions. This may be due to the antioxidative capacity within the granulocyte, namely, by catalase or glutathione (GSH)-peroxidase,31 or proteolytic degradation. However, the evidence that H2O2-positive cells could be detected even after 8 hours indicates that GO is rather stable. To further evaluate the stability of GO, enzyme activity was analyzed in HBSS at acidic pH, in the presence of MPO, in supernatants of granulocytes after degranulation with cytochalasin B/NfMLP, and in extracts of granulocytes. In each of these systems, GO activity was not reduced after a 2-hour incubation period at 37°C compared to the control system (GO in HBSS, pH 7.4; data not shown). Time-dependent stability and activity of GO is certainly related to the different localizations of GO within the granulocytes (in phagolysosomes, liposomes encapsulated in the cytoplasm or released into the cytoplasm). Therefore, although the contact is closest in phagolysosomes, a colocalization of bacteria and GO is not a mandatory supposition for optimal activity, because degradation of GO may be faster due to presence of proteolytic enzymes. The H2O2 produced in vacuoles after entry of
glucose into the GOLs or after release of GO could easily diffuse into
bacteria-containing phagolysosomes. Within these phagolysosomes HOCl
can be produced for bacterial killing, provided that
H2O2 was able to escape degradation by catalase
or GSH-peroxidase. Generally, H2O2 can easily
penetrate through liposomal bilayers. The permeability coefficient for
passive H2O2 permeation through liposomal
membranes is very high (approximately 10 In contrast, compared to an active membrane transport, the passive
glucose permeation through liposomal membranes is some orders of
magnitude lower (about 5 × 10 Our investigations confirmed that CGD granulocytes have normal MPO activity. Therefore, CGD granulocytes treated with GOLs demonstrated normal production of HOCl. Compared to the direct incubation of GOLs with CGD granulocytes, the amount of produced HOCl was still 15% after removal of nonincorporated GOLs, indicating that a considerable part of GO is taken up by the granulocytes. The degranulation assay using the ADVIA120 flow cytometry system36 did not show evidence that MPO is degranulated under liposomal influence. However, it cannot be completely excluded that a small amount of HOCl is produced outside the cell because of some extracellular membrane binding of GOLs and a small spontaneous release of MPO. HOCl is a very strong oxidant and uncontrolled production in the extracellular space can be harmful. Therefore, possible side effects are the focus of current studies. We demonstrated an enhanced and effective killing of S aureus by CGD cells in the presence of GOLs. The successful killing of S aureus by CGD granulocytes treated with GOL is the consequence of restored H2O2 and HOCl production. In general, CGD cells show a normal response toward chemotactic agents.37,38 We found that granulocytes treated with GOLs were still able to migrate along NfMLP and LTB4 gradients. The general decrease in chemotactic activity of GOL-treated granulocytes might be due to the oxidative stress mediated by H2O2. As already stated above in the context of MPO release and potential extracellular HOCl production, an important point for a potential clinical application of GOLs for in vivo treatment of CGD is the identification of potential side effects and the question whether the antioxidative system of whole blood could cope with the enhanced oxidative stress. According to our investigations in whole blood samples, this is obviously the case. Using GOLs containing up to 2 U/mL GO, the continuously generated H2O2 could be successfully removed. Decrease of glucose under these in vitro conditions was moderate (data not shown). Furthermore, it can be assumed that in a dynamic in vivo situation (circulating blood with compensatory regulation during potential decrease of blood glucose) the glucose consumption is negligible. Our results show that methemoglobin levels never exceeded the normal range between 0.8% (nonsmoker) to 2.7% (smoker) except at very high concentrations of GO encapsulated in liposomes (approximately 2 U/mL, 10 mM total lipid). The 1 mM lipid concentration (0.2 U/mL) used in all experiments showed almost no methemoglobin elevation, which can be explained by the high antioxidative capacity of whole blood. Samoszuk and colleagues39,40 reported a higher formation of methemoglobin in mice after injection of free GO (1 U/g body weight); its generation was strongly reduced by lower concentrations of free GO. With regard to liver abscesses being a severe complication in CGD, a
rapid elimination of conventional negatively charged liposomes by liver
and spleen could be a further advantage for bactericidal activity of
GOLs. In addition to interferon-
We thank Thérèse Bruggmann and Dr Mathias Höchli (Laboratory for Electron Microscopy, Zurich) for the preparation of electron microscopy and confocal laser microscopy, and Prof Reinhard Seger (University Children's Hospital, Zurich) for critical reading of the manuscript.
Submitted June 6, 2001; accepted July 17, 2001.
Supported by the Reinhold-Beitlich-Stiftung and the fortüne-program (project 717-0-0), Tübingen, Germany, and the Schweizerische Vereinigung für Angeborene Immundefekte (SVAI), Zürich, Switzerland.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Claudia E. Gerber, University Children's Hospital, Department of Hematology and Oncology, Hoppe-Seyler-Str 1, D-72076 Tübingen, Germany; e-mail: claudia.gerber{at}med.uni-tuebingen.de.
1. Dinauer MC. Leukocyte function and nonmalignant leukocyte disorders. Curr Opin Pediatr. 1993;5:80-87[Medline] [Order article via Infotrieve].
2.
Roos D, de Boer M, Kuribayashi F, et al.
Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.
Blood.
1996;87:1663-1681
3.
Babior BM.
NADPH oxidase: an update.
Blood.
1999;93:1464-1476 4. Hurst JK, Barrette WC. Leukocyte oxygen activation and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol. 1989;24:271-328. 5. Fischer A, Segal WW, Seger R, Weening RS. The management of chronic granulomatous disease. Eur J Pediatr. 1993;152:896-899[CrossRef][Medline] [Order article via Infotrieve]. 6. Storm G, Crommelin DJA. Liposomes: quo vadis? PSTT. 1998;1:19-31. 7. Scherphof GL, Crommelin DJA. Cells involved in removing liposomes from the blood circulation: why are they so special? J Liposome Res. 1996;6:19-32.
8.
Johnston RB, Baehner RL.
Improvement of leukocyte bactericidal activity in chronic granulomatous disease.
Blood.
1970;35:350-355 9. Root RK. Correction of the function of chronic granulomatous disease (CGD) granulocytes (PMN) with extracellular H2O2. Clin Res. 1974;22:452A. 10. Ismail G, Boxer LA, Baehner RL. Utilization of liposomes for correction of the metabolic and bactericidal deficiencies in chronic granulomatous disease. Pediatr Res. 1979;13:769-773[Medline] [Order article via Infotrieve]. 11. Pegram PS, De Chatelet LR, McCall CE. Comparison of myeloperoxidase activity in leukocytes from normal subjects and patients with chronic granulomatous disease. J Infect Dis. 1978;138:699-702[Medline] [Order article via Infotrieve]. 12. Gerber CE, Kuçi S, Zipfel M, Niethammer D, Bruchelt G. Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur J Clin Chem Clin Biochem. 1996;34:901-908[Medline] [Order article via Infotrieve]. 13. Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation: hydrogen peroxide formation and the role of catalase. Eur J Biochem. 1972;25:420-430[Medline] [Order article via Infotrieve]. 14. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory manual of neutrophil function. New York, NY: Raven Press; 1986:60-64. 15. Cline MJ. Leukocyte function. New York, NY: Churchill Livingstone; 1981:46-48. 16. Bentwood BJ, Henson PM. The sequential release of granule constituents from human neutrophils. J Immunol. 1980;124:855-862[Abstract]. 17. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J. 1995;9:200-209[Abstract]. 18. Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol. 1997;34:279-290[Medline] [Order article via Infotrieve]. 19. Liese JG, Jendrossek V, Jansson A, et al. Chronic granulomatous disease in adults. Lancet. 1995;346:220-223[CrossRef][Medline] [Order article via Infotrieve].
20.
Ozsahin H, von Planta M, Müller I, et al.
Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.
Blood.
1998;92:2719-2724 21. Lee KD, Hong K, Papahadjopoulos D. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge. Biochim Biophys Acta. 1992;1103:185-197[Medline] [Order article via Infotrieve]. 22. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and application. J Immunol Methods. 1994;174:83-93[CrossRef][Medline] [Order article via Infotrieve]. 23. Harashima H, Sakata K, Funato K, Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharmacol Res. 1994;11:402-406. 24. Scherphof GL, Kamps JAAM. Receptor versus non-receptor clearance of liposomes. Adv Drug Delivery Rev. 1998;32:81-97[CrossRef][Medline] [Order article via Infotrieve]. 25. Ho SC, Huang L. A novel cytochemical marker for liposome decomposition in lysosomes. J Histochem Cytochem. 1983;31:404-410[Abstract]. 26. Petty HR, McConnell HM. Cytochemical study of liposome and lipid vesicle phagocytosis. Biochim Biophys Acta. 1983;735:77-85[Medline] [Order article via Infotrieve]. 27. Rothe G, Valet G. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol. 1994;233:539-548[Medline] [Order article via Infotrieve]. 28. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89-97[CrossRef][Medline] [Order article via Infotrieve].
29.
Ohno Y, Gallin JI.
Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils.
J Biol Chem.
1985;260:8438-8446 30. Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis. 1990;162:523-528[Medline] [Order article via Infotrieve]. 31. Roos D, Weening RS, Voetman AA. Protection of human neutrophils against oxidative damage. Agents Actions. 1980;10:528-535[CrossRef][Medline] [Order article via Infotrieve].
32.
Mathai JC, Sitaramam V.
Stretch sensitivity of transmembrane mobility of hydrogen peroxide through voids in the bilayer.
J Biol Chem.
1994;269:17784-17793
33.
Subczynski WK, Hyde JS, Kusumi A.
Oxygen permeability of phosphatidylcholine-cholesterol membranes.
Proc Natl Acad Sci U S A.
1989;86:4474-4478 34. Wood RE, Wirth FP, Morgan HE. Glucose permeability of lipid bilayer membranes. Biochim Biophys Acta. 1968;163:171-178[Medline] [Order article via Infotrieve].
35.
Tan AS, Ahmed N, Berridge MV.
Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor.
Blood.
1998;91:649-655 36. Zipfel M, Carmine TC, Gerber C, Niethammer D, Bruchelt G. Evidence for the activation of myloperoxidase by f-Meth-Leu-Phe prior to its release from neutrophil granulocytes. Biochem Biophys Res Commun. 1997;232:209-212[CrossRef][Medline] [Order article via Infotrieve]. 37. White CJ, Gallin JI. Phagocyte defects. Clin Immunol Immunopathol. 1986;40:50-61[CrossRef][Medline] [Order article via Infotrieve]. 38. Ottonello L, Dapino P, Pastorino G, Dallegri F, Sacchetti C. Neutrophil dysfunction and increased susceptibility to infection. Eur J Clin Invest. 1995;25:687-692[Medline] [Order article via Infotrieve].
39.
Samoszuk MK, Ehrlich D, Ramzi E.
Preclinical safety studies of glucose oxidase.
J Pharmacol Exp Ther.
1993;266:1643-1648
40.
Samoszuk MK, Wimley WC, Nguyen V.
Eradication of interleukin-5 transfected J558L plasmocytomas in mice by hydrogen peroxide-generating stealth liposomes.
Cancer Res.
1996;56:87-90
41.
Gallin JI, Farber JM, Holland SM, Nutman TB.
Interferon-gamma in the management of infectious diseases (clinical conference).
Ann Intern Med.
1995;123:216-224 42. Muhlebach TJ, Gabay J, Nathan CF, et al. Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four antimicrobial proteins. Clin Exp Immunol. 1992;88:203-206[Medline] [Order article via Infotrieve]. 43. Malech HL. Progress in gene therapy for chronic granulomatous disease. J Infect Dis. 1999;179(suppl l2):S318-325.
44.
Dinauer MC, Li LL, Björgvinsdóttir H, Ding C, Pech N.
Long-term correction of phagocyte NADPH oxidase-activity by retroviral-mediated gene trasfer in murine X-linked chronic granulomatous disease.
Blood.
1999;94:914-922 45. Roesler J, Hockertz S, Vogt B, Lohmann-Matthes ML. Staphylococci surviving intracellularly in phagocytes from patients suffering from chronic granulomatous disease are killed in vitro by antibiotics encapsulated in liposomes. J Clin Invest. 1991;88:1224-1229.
46.
Pallister CJ, Johnson EM, Warnock DW, Elliot PJ, Reeves DF.
In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.
J Antimicrob Chemother.
1992;30:313-320 47. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376[Medline] [Order article via Infotrieve].
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Decleva, R. Menegazzi, S. Busetto, P. Patriarca, and P. Dri Common methodology is inadequate for studies on the microbicidal activity of neutrophils J. Leukoc. Biol., January 1, 2006; 79(1): 87 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. De Larco, B. R. K. Wuertz, and L. T. Furcht The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 Clin. Cancer Res., August 1, 2004; 10(15): 4895 - 4900. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
indicates EPC:SPS:Chol; 
, EPC:EPG:Chol (both 4:3:3 mole
ratio and negatively charged); 
, EPC:Chol (7:3 mole
ratio, uncharged). Results of 2-group t test are
marked with asterisk; P < .001. (B) FACS analysis of the
time-dependent uptake of rhodamine-B-PE-labeled liposomes by
granulocytes (5 × 105 cells/mL). Liposomal lipid
concentration is 1 mM. Values are given as percentage of the whole
population, showing a single experiment of 3 independent experiments;
, EPC:EPG:Chol (both 4:3:3 mole
ratio); 
, EPC:Chol (70:30 mol%).
,
CGD granulocytes with continuous incubation of liposomes; 
, CGD
granulocytes preincubated with liposomes. Results of 2-group
t test are marked with asterisk; P < .05.
, PBS/Gluc plus GOLs (1 mM lipid; 0.2 U/mL GO); 
, PBS/Gluc plus GOLs
(0.01 mM lipid; 0.002 U/mL GO).
prophylaxis, which is thought to
augment more oxidant-independent antimicrobial pathways,